|
Volumn 18, Issue 3, 2008, Pages 120-121
|
Durability of clinical responses to anti-HIV therapies
|
Author keywords
Antiretroviral therapy; HIV AIDS
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ENFUVIRTIDE;
RITONAVIR;
VIRUS RNA;
CD4 LYMPHOCYTE COUNT;
CLINICAL PRACTICE;
DEATH;
EDITORIAL;
FOLLOW UP;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MEDICAL INFORMATION;
MEDICAL SERVICE;
MORTALITY;
POPULATION;
TREATMENT FAILURE;
TREATMENT RESPONSE;
VIROLOGY;
VIRUS LOAD;
ADOLESCENT;
ADULT;
AGED;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CONTINENTAL POPULATION GROUPS;
FEMALE;
HIV;
HIV INFECTIONS;
HUMANS;
MALE;
MIDDLE AGED;
SEXUAL BEHAVIOR;
SOCIAL CLASS;
SUBSTANCE ABUSE, INTRAVENOUS;
TREATMENT OUTCOME;
|
EID: 40849102592
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (1)
|
References (9)
|